VANDA Pharmaceuticals - Investor Relations - IR Home
Data as of Jul/22/2019 12:40 PM EDT Minimum 15 minutes delayed. Refresh quote
Copyright West LLC. Minimum 15 minutes delayed.
Primary IR Contact
For members of the press or investor community who wish to obtain more information about Vanda, please contact
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals, Inc.
(202) 734-3428 email@example.com